Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

Primary tumors facilitate metastasis by directing bone marrowderived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 108; no. 39; pp. 16369 - 16374
Main Authors Wong, Carmen Chak-Lui, Gilkes, Daniele M., Zhang, Huafeng, Chen, Jasper, Wei, Hong, Chaturvedi, Pallavi, Fraley, Stephanie I., Wong, Chun-Ming, Khoo, Ui-Soon, Ng, Irene Oi-Lin, Wirtz, Denis, Semenza, Gregg L.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 27.09.2011
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Primary tumors facilitate metastasis by directing bone marrowderived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, and LOX-like 4, which catalyze collagen cross-linking in the lungs before BMDC recruitment. Only a subset of LOX family members was expressed in any individual breast cancer, but HIF-1 was required for expression in each case. Knockdown of HIF-1 or hypoxia-induced LOX family members reduced collagen cross-linking, CD11b⁺ BMDC recruitment and metastasis formation in the lungs of mice after orthotopic transplantation of human breast cancer cells. Metastatic niche formation is an HIF-1-dependent event during breast cancer progression.
AbstractList Primary tumors facilitate metastasis by directing bone marrow-derived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, and LOX-like 4, which catalyze collagen cross-linking in the lungs before BMDC recruitment. Only a subset of LOX family members was expressed in any individual breast cancer, but HIF-1 was required for expression in each case. Knockdown of HIF-1 or hypoxia-induced LOX family members reduced collagen cross-linking, CD11b + BMDC recruitment, and metastasis formation in the lungs of mice after orthotopic transplantation of human breast cancer cells. Metastatic niche formation is an HIF-1–dependent event during breast cancer progression.
Primary tumors facilitate metastasis by directing bone marrow-derived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, and LOX-like 4, which catalyze collagen cross-linking in the lungs before BMDC recruitment. Only a subset of LOX family members was expressed in any individual breast cancer, but HIF-1 was required for expression in each case. Knockdown of HIF-1 or hypoxia-induced LOX family members reduced collagen cross-linking, CD11b+ BMDC recruitment, and metastasis formation in the lungs of mice after orthotopic transplantation of human breast cancer cells. Metastatic niche formation is an HIF-1-dependent event during breast cancer progression. [PUBLICATION ABSTRACT]
Primary tumors facilitate metastasis by directing bone marrow-derived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, and LOX-like 4, which catalyze collagen cross-linking in the lungs before BMDC recruitment. Only a subset of LOX family members was expressed in any individual breast cancer, but HIF-1 was required for expression in each case. Knockdown of HIF-1 or hypoxia-induced LOX family members reduced collagen cross-linking, CD11b + BMDC recruitment, and metastasis formation in the lungs of mice after orthotopic transplantation of human breast cancer cells. Metastatic niche formation is an HIF-1–dependent event during breast cancer progression.
Primary tumors facilitate metastasis by directing bone marrowderived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, and LOX-like 4, which catalyze collagen cross-linking in the lungs before BMDC recruitment. Only a subset of LOX family members was expressed in any individual breast cancer, but HIF-1 was required for expression in each case. Knockdown of HIF-1 or hypoxia-induced LOX family members reduced collagen cross-linking, CD11b⁺ BMDC recruitment and metastasis formation in the lungs of mice after orthotopic transplantation of human breast cancer cells. Metastatic niche formation is an HIF-1-dependent event during breast cancer progression.
Primary tumors facilitate metastasis by directing bone marrow-derived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, and LOX-like 4, which catalyze collagen cross-linking in the lungs before BMDC recruitment. Only a subset of LOX family members was expressed in any individual breast cancer, but HIF-1 was required for expression in each case. Knockdown of HIF-1 or hypoxia-induced LOX family members reduced collagen cross-linking, CD11b(+) BMDC recruitment, and metastasis formation in the lungs of mice after orthotopic transplantation of human breast cancer cells. Metastatic niche formation is an HIF-1-dependent event during breast cancer progression.Primary tumors facilitate metastasis by directing bone marrow-derived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, and LOX-like 4, which catalyze collagen cross-linking in the lungs before BMDC recruitment. Only a subset of LOX family members was expressed in any individual breast cancer, but HIF-1 was required for expression in each case. Knockdown of HIF-1 or hypoxia-induced LOX family members reduced collagen cross-linking, CD11b(+) BMDC recruitment, and metastasis formation in the lungs of mice after orthotopic transplantation of human breast cancer cells. Metastatic niche formation is an HIF-1-dependent event during breast cancer progression.
Author Wirtz, Denis
Wong, Chun-Ming
Semenza, Gregg L.
Chaturvedi, Pallavi
Chen, Jasper
Wong, Carmen Chak-Lui
Zhang, Huafeng
Fraley, Stephanie I.
Gilkes, Daniele M.
Khoo, Ui-Soon
Ng, Irene Oi-Lin
Wei, Hong
Author_xml – sequence: 1
  givenname: Carmen Chak-Lui
  surname: Wong
  fullname: Wong, Carmen Chak-Lui
– sequence: 2
  givenname: Daniele M.
  surname: Gilkes
  fullname: Gilkes, Daniele M.
– sequence: 3
  givenname: Huafeng
  surname: Zhang
  fullname: Zhang, Huafeng
– sequence: 4
  givenname: Jasper
  surname: Chen
  fullname: Chen, Jasper
– sequence: 5
  givenname: Hong
  surname: Wei
  fullname: Wei, Hong
– sequence: 6
  givenname: Pallavi
  surname: Chaturvedi
  fullname: Chaturvedi, Pallavi
– sequence: 7
  givenname: Stephanie I.
  surname: Fraley
  fullname: Fraley, Stephanie I.
– sequence: 8
  givenname: Chun-Ming
  surname: Wong
  fullname: Wong, Chun-Ming
– sequence: 9
  givenname: Ui-Soon
  surname: Khoo
  fullname: Khoo, Ui-Soon
– sequence: 10
  givenname: Irene Oi-Lin
  surname: Ng
  fullname: Ng, Irene Oi-Lin
– sequence: 11
  givenname: Denis
  surname: Wirtz
  fullname: Wirtz, Denis
– sequence: 12
  givenname: Gregg L.
  surname: Semenza
  fullname: Semenza, Gregg L.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21911388$$D View this record in MEDLINE/PubMed
BookMark eNp9kstv1DAQhy1URLcLZ04giwtc0voVPy5IqAKKVIkL3JAsrzNpvUrsxU4Q_e9x2G0LleBkzcw3v3l4TtBRTBEQek7JKSWKn-2iK6eUUi40p0Q_QitKDG2kMOQIrQhhqtGCiWN0UsqWEGJaTZ6gY0ZNzdF6hb5d3OzSz-CaELvZh80AuHd-ShlTHAp2eHRlgowzXM2DW_ypx5sM1Yu9i76GRpiq5abgcQz-ugqkPFYzxafoce-GAs8O7xp9_fD-y_lFc_n546fzd5eNb2U7NQDac88Ea_u-dkiEcsI4zpVgoMlG6W5DpAZBHSiluO-7DjrCoTOyM6KCa_R2r7ubNyN0HuKU3WB3OYwu39jkgv07EsO1vUo_LKeaKSaqwOuDQE7fZyiTHUPxMAwuQpqL1UZoKmUtvkZv_ksyo6WQ0vAFffUA3aY5x7qIRU9xLtql8ss_W7_r-faHKtDuAZ9TKRl668P0e7t1kjBYSuxyCXa5BHt_CTXv7EHerfS_M_ChlSVwT2vLjaWS16HW6MUe2ZZ6CneMoLxlmrT8F217ypE
CitedBy_id crossref_primary_10_1080_14712598_2016_1196179
crossref_primary_10_2174_0115665240268661231128094831
crossref_primary_10_1007_s11033_023_08852_0
crossref_primary_10_1016_j_trecan_2016_10_016
crossref_primary_10_1186_s12885_015_1741_8
crossref_primary_10_1074_jbc_M111_278630
crossref_primary_10_1016_j_heliyon_2023_e16292
crossref_primary_10_5306_wjco_v5_i2_149
crossref_primary_10_18632_oncotarget_8152
crossref_primary_10_1158_0008_5472_CAN_11_3873
crossref_primary_10_1074_jbc_RA119_007674
crossref_primary_10_1038_s41388_018_0320_2
crossref_primary_10_1038_onc_2013_171
crossref_primary_10_2217_fon_13_63
crossref_primary_10_1016_j_jconrel_2025_02_019
crossref_primary_10_1158_1078_0432_CCR_18_1325
crossref_primary_10_1038_bjc_2017_247
crossref_primary_10_1038_s41389_018_0052_8
crossref_primary_10_1016_j_bbcan_2023_189027
crossref_primary_10_1126_science_aaf4405
crossref_primary_10_2217_fon_14_39
crossref_primary_10_1146_annurev_pathol_012513_104720
crossref_primary_10_32604_or_2024_043482
crossref_primary_10_1016_j_biomaterials_2019_01_003
crossref_primary_10_3390_ijms23116249
crossref_primary_10_1016_j_tcb_2015_09_009
crossref_primary_10_1152_ajprenal_00239_2022
crossref_primary_10_18632_oncotarget_27974
crossref_primary_10_1126_sciadv_ade5111
crossref_primary_10_3390_bioengineering7030115
crossref_primary_10_1038_onc_2014_23
crossref_primary_10_1038_ncomms2677
crossref_primary_10_1007_s11010_013_1600_3
crossref_primary_10_1016_j_isci_2021_102179
crossref_primary_10_1007_s00018_014_1764_3
crossref_primary_10_1007_s12307_014_0158_2
crossref_primary_10_1002_adma_202108908
crossref_primary_10_1007_s13402_021_00634_9
crossref_primary_10_1007_s11523_013_0277_6
crossref_primary_10_1038_s41467_020_16199_4
crossref_primary_10_1177_0300060513505491
crossref_primary_10_1021_acsnano_1c00616
crossref_primary_10_3389_fonc_2022_997235
crossref_primary_10_1016_j_gene_2025_149312
crossref_primary_10_1186_s40644_020_00362_7
crossref_primary_10_2174_0118715206290816240220062545
crossref_primary_10_3389_fphar_2018_00006
crossref_primary_10_1172_JCI137553
crossref_primary_10_1186_s12967_020_02667_4
crossref_primary_10_1007_s00109_013_1102_5
crossref_primary_10_1080_15384047_2017_1385681
crossref_primary_10_1016_j_isci_2020_100868
crossref_primary_10_18632_oncotarget_11743
crossref_primary_10_1038_nnano_2012_167
crossref_primary_10_1007_s13402_018_0376_6
crossref_primary_10_1016_j_ejcb_2022_151234
crossref_primary_10_3390_cancers14235930
crossref_primary_10_18632_oncotarget_11503
crossref_primary_10_1002_ijc_27901
crossref_primary_10_1016_j_cej_2023_144271
crossref_primary_10_1172_JCI95089
crossref_primary_10_1152_ajpgi_00425_2012
crossref_primary_10_3390_ijms241814405
crossref_primary_10_18632_oncotarget_14450
crossref_primary_10_1136_bmjonc_2023_000154
crossref_primary_10_1016_j_ejca_2013_03_002
crossref_primary_10_1038_s41389_017_0011_9
crossref_primary_10_1016_j_bbcan_2020_188435
crossref_primary_10_1016_j_semcancer_2023_11_001
crossref_primary_10_1038_s41416_024_02691_x
crossref_primary_10_1158_2326_6066_CIR_22_0099
crossref_primary_10_1016_j_jconrel_2018_10_035
crossref_primary_10_1073_pnas_1614035114
crossref_primary_10_1158_0008_5472_CAN_16_3152
crossref_primary_10_1016_j_trecan_2016_06_004
crossref_primary_10_1667_RADE_20_00109_1
crossref_primary_10_26508_lsa_202403053
crossref_primary_10_1158_1078_0432_CCR_11_1591
crossref_primary_10_1038_s41388_019_0932_1
crossref_primary_10_1038_mt_2011_294
crossref_primary_10_1016_j_bbcan_2017_05_004
crossref_primary_10_1038_nrc3726
crossref_primary_10_1158_0008_5472_CAN_14_3000
crossref_primary_10_1364_BOE_499286
crossref_primary_10_2217_fon_13_92
crossref_primary_10_1016_j_bbcan_2014_07_011
crossref_primary_10_3389_fonc_2023_1142907
crossref_primary_10_3109_10409238_2013_838205
crossref_primary_10_1073_pnas_1406655111
crossref_primary_10_1016_j_biomaterials_2016_04_027
crossref_primary_10_2217_fon_12_105
crossref_primary_10_1016_j_ijpharm_2019_118894
crossref_primary_10_1186_1756_9966_31_75
crossref_primary_10_1142_S1793048020300029
crossref_primary_10_1007_s11033_023_08251_5
crossref_primary_10_3390_ijms23179507
crossref_primary_10_1016_j_cbi_2017_04_015
crossref_primary_10_1146_annurev_bioeng_071811_150028
crossref_primary_10_1155_2017_4015039
crossref_primary_10_1177_1010428318776822
crossref_primary_10_15252_embj_201489975
crossref_primary_10_1158_0008_5472_CAN_12_3963
crossref_primary_10_3390_cells8050401
crossref_primary_10_3390_cells11193007
crossref_primary_10_1016_j_jtemb_2019_06_008
crossref_primary_10_3390_ijms25179303
crossref_primary_10_1038_s41419_019_2155_3
crossref_primary_10_1158_1541_7786_MCR_12_0629
crossref_primary_10_3389_fcell_2024_1335636
crossref_primary_10_1016_j_biomaterials_2016_04_016
crossref_primary_10_1016_j_joca_2013_01_007
crossref_primary_10_1631_jzus_B2300067
crossref_primary_10_3390_ijms18112321
crossref_primary_10_3389_fonc_2022_876451
crossref_primary_10_3892_or_2023_8600
crossref_primary_10_1242_dmm_048942
crossref_primary_10_1073_pnas_2020490118
crossref_primary_10_1002_jcb_29000
crossref_primary_10_1007_s10555_013_9420_1
crossref_primary_10_1002_biot_201900107
crossref_primary_10_1111_febs_16605
crossref_primary_10_1074_jbc_M112_442939
crossref_primary_10_1371_journal_pone_0129356
crossref_primary_10_1080_0284186X_2017_1301680
crossref_primary_10_1016_j_neo_2017_11_010
crossref_primary_10_3390_cancers13123070
crossref_primary_10_1002_biof_1702
crossref_primary_10_1158_0008_5472_CAN_23_2028
crossref_primary_10_1038_nature11207
crossref_primary_10_1101_cshperspect_a041326
crossref_primary_10_3390_ijms17101669
crossref_primary_10_1016_j_xphs_2023_05_012
crossref_primary_10_18632_oncotarget_4612
crossref_primary_10_3389_fimmu_2019_00172
crossref_primary_10_1007_s12011_022_03296_2
crossref_primary_10_1093_bib_bbac320
crossref_primary_10_5665_sleep_5052
crossref_primary_10_1002_sono_12476
crossref_primary_10_1007_s12672_023_00836_7
crossref_primary_10_1021_acsanm_3c01403
crossref_primary_10_1039_C5RA15191K
crossref_primary_10_1038_s41419_025_07461_y
crossref_primary_10_18632_oncotarget_2427
crossref_primary_10_3390_cancers11070978
crossref_primary_10_1158_0008_5472_CAN_20_2876
crossref_primary_10_1160_TH14_01_0024
crossref_primary_10_3389_fonc_2019_00219
crossref_primary_10_1093_carcin_bgt241
crossref_primary_10_1016_j_yexcr_2017_02_024
crossref_primary_10_1158_0008_5472_CAN_18_2616
crossref_primary_10_3389_fphar_2022_883998
crossref_primary_10_1158_1541_7786_MCR_16_0118
crossref_primary_10_1016_j_prp_2023_154676
crossref_primary_10_1016_j_ccell_2023_02_018
crossref_primary_10_1002_hep_27320
crossref_primary_10_1007_s00109_011_0855_y
crossref_primary_10_1038_nrclinonc_2013_29
crossref_primary_10_1021_acsnano_3c11260
crossref_primary_10_3389_fcell_2016_00027
crossref_primary_10_1002_hep_28655
crossref_primary_10_1016_j_neo_2019_03_003
crossref_primary_10_1038_nphys2464
crossref_primary_10_1016_j_drup_2013_01_001
crossref_primary_10_1021_acsnano_0c05617
crossref_primary_10_1038_srep21520
crossref_primary_10_3389_fphar_2023_1108915
crossref_primary_10_1016_j_trecan_2016_05_006
crossref_primary_10_1038_srep09650
crossref_primary_10_1042_BST20140118
crossref_primary_10_1007_s00005_018_0531_9
crossref_primary_10_1016_j_canlet_2014_12_013
crossref_primary_10_1371_journal_pone_0115036
crossref_primary_10_1042_CS20150451
crossref_primary_10_1073_pnas_1217394109
crossref_primary_10_1111_jcmm_12004
crossref_primary_10_3390_cancers11081128
crossref_primary_10_1016_j_jcmgh_2017_02_004
crossref_primary_10_1016_j_mtadv_2022_100289
crossref_primary_10_1172_JCI64993
crossref_primary_10_1038_ncb3295
crossref_primary_10_1172_JCI90253
crossref_primary_10_1172_JCI159839
crossref_primary_10_1007_s00726_023_03343_9
crossref_primary_10_1186_1423_0127_19_102
crossref_primary_10_3390_cells10092371
crossref_primary_10_3390_ijms21218027
crossref_primary_10_1007_s12094_023_03107_7
crossref_primary_10_1016_j_addr_2021_113852
crossref_primary_10_1158_0008_5472_CAN_13_0523
crossref_primary_10_1038_nrc3319
crossref_primary_10_1073_pnas_1410041111
crossref_primary_10_1084_jem_20200712
crossref_primary_10_3390_ijms19113523
crossref_primary_10_3390_ijms22189819
crossref_primary_10_1002_mc_22124
crossref_primary_10_1186_s13046_018_0761_z
crossref_primary_10_1016_j_freeradbiomed_2014_01_033
crossref_primary_10_1016_j_ijpharm_2018_09_034
crossref_primary_10_1158_1541_7786_MCR_16_0338
crossref_primary_10_1016_j_jtemb_2024_127436
crossref_primary_10_1016_j_molmed_2012_08_001
crossref_primary_10_1038_s41563_020_00849_5
crossref_primary_10_3390_genes13091585
crossref_primary_10_3390_bios14040175
crossref_primary_10_3390_ijms23031636
crossref_primary_10_1152_ajpcell_00326_2015
crossref_primary_10_1080_08958378_2016_1271841
crossref_primary_10_1016_j_ijpharm_2014_10_065
crossref_primary_10_1016_j_biopha_2022_113861
crossref_primary_10_1089_wound_2014_0528
crossref_primary_10_1146_annurev_pathol_020117_044127
crossref_primary_10_32604_Oncologie_2021_016958
crossref_primary_10_3389_fonc_2018_00031
crossref_primary_10_1016_j_semcancer_2012_02_006
crossref_primary_10_1016_j_semcancer_2012_02_007
crossref_primary_10_1186_bcr3087
crossref_primary_10_1038_s42003_021_02648_3
crossref_primary_10_1021_acsami_3c00603
crossref_primary_10_1080_2162402X_2016_1271858
crossref_primary_10_1093_cvr_cvv214
crossref_primary_10_1158_0008_5472_CAN_15_2621
crossref_primary_10_1042_BJ20130592
crossref_primary_10_1016_j_surfcoat_2020_126293
crossref_primary_10_3109_09553002_2014_916841
crossref_primary_10_1016_j_scitotenv_2024_173448
crossref_primary_10_1093_jmcb_mju039
crossref_primary_10_3390_cells10030678
crossref_primary_10_18632_oncotarget_8570
crossref_primary_10_1038_s41598_023_42178_y
crossref_primary_10_3390_ijms241411546
crossref_primary_10_1111_jcmm_15056
crossref_primary_10_1002_cam4_3130
crossref_primary_10_1007_s10585_023_10224_8
crossref_primary_10_1016_j_immuni_2014_09_008
crossref_primary_10_3389_fonc_2018_00249
crossref_primary_10_1002_cmdc_202300331
crossref_primary_10_1016_j_molstruc_2018_09_072
crossref_primary_10_1016_j_artere_2017_01_005
crossref_primary_10_1074_jbc_M112_374587
crossref_primary_10_15252_embr_201540107
crossref_primary_10_1016_j_jcmgh_2023_03_001
crossref_primary_10_1038_onc_2014_164
crossref_primary_10_1038_s41419_021_04391_3
crossref_primary_10_1007_s10120_015_0510_3
crossref_primary_10_1016_j_arteri_2017_01_004
crossref_primary_10_1093_carcin_bgu018
crossref_primary_10_1007_s00066_013_0326_1
crossref_primary_10_3389_fonc_2022_1019153
crossref_primary_10_3390_ijms22010089
crossref_primary_10_1038_s41590_024_01960_4
crossref_primary_10_4161_cc_22820
crossref_primary_10_1007_s12307_012_0105_z
crossref_primary_10_3390_antiox10020312
crossref_primary_10_1016_j_semcancer_2019_08_012
crossref_primary_10_1111_febs_12148
crossref_primary_10_1002_jcb_28734
crossref_primary_10_1186_s12967_024_05199_3
crossref_primary_10_1098_rstb_2016_0485
crossref_primary_10_1002_adfm_202010283
crossref_primary_10_1016_j_ajpath_2017_04_007
crossref_primary_10_3390_cancers14246054
crossref_primary_10_1177_09731296241294143
crossref_primary_10_7314_APJCP_2013_14_6_3613
crossref_primary_10_1038_s41467_017_00530_7
crossref_primary_10_1016_j_phrs_2016_07_023
crossref_primary_10_1038_onc_2012_578
crossref_primary_10_15252_embr_201540759
crossref_primary_10_3389_fonc_2024_1331355
crossref_primary_10_1002_adhm_202101761
crossref_primary_10_1007_s10585_018_9930_x
crossref_primary_10_3389_fonc_2023_1163786
crossref_primary_10_3389_fcell_2024_1421629
crossref_primary_10_3389_fonc_2020_602416
crossref_primary_10_1038_srep17576
crossref_primary_10_3389_fonc_2018_00189
crossref_primary_10_1016_j_tips_2020_01_001
crossref_primary_10_1073_pnas_1321510111
crossref_primary_10_1021_acsabm_8b00837
crossref_primary_10_1073_pnas_1214019109
crossref_primary_10_3390_cancers14030539
crossref_primary_10_1016_j_bbamcr_2015_05_036
crossref_primary_10_1186_s12967_019_2058_1
crossref_primary_10_3390_cancers11050705
crossref_primary_10_1158_1078_0432_CCR_13_1059
crossref_primary_10_1158_0008_5472_CAN_12_2233
crossref_primary_10_1371_journal_pone_0168572
crossref_primary_10_1038_s41419_018_1291_5
crossref_primary_10_20935_AcadOnco7445
crossref_primary_10_1038_onc_2016_182
crossref_primary_10_1093_cvr_cvac089
crossref_primary_10_1007_s10555_016_9650_0
crossref_primary_10_1073_pnas_1520032112
crossref_primary_10_1002_adhm_201900826
crossref_primary_10_1186_s13578_019_0325_8
crossref_primary_10_1111_jcmm_17066
crossref_primary_10_1186_s43556_020_00022_z
crossref_primary_10_1007_s10930_025_10264_x
crossref_primary_10_1089_ars_2019_7935
crossref_primary_10_1016_j_arcmed_2019_12_002
crossref_primary_10_3389_fonc_2021_652266
crossref_primary_10_1007_s13277_013_1579_0
crossref_primary_10_18632_oncotarget_25782
crossref_primary_10_1038_s41598_022_19977_w
crossref_primary_10_1523_JNEUROSCI_0663_20_2020
crossref_primary_10_1007_s10555_023_10146_7
crossref_primary_10_2174_0115680096280750240123054936
crossref_primary_10_1016_j_aca_2014_05_045
crossref_primary_10_1093_hropen_hoae002
crossref_primary_10_1111_febs_15223
crossref_primary_10_1186_s13062_023_00365_x
crossref_primary_10_1016_j_tips_2012_01_005
crossref_primary_10_1038_s41551_018_0307_x
crossref_primary_10_3390_biom12111684
crossref_primary_10_1038_s41388_021_01659_y
crossref_primary_10_1093_bib_bbaa413
crossref_primary_10_1126_scitranslmed_aan2966
crossref_primary_10_1039_c3sm50798j
crossref_primary_10_3390_cancers13236062
crossref_primary_10_1007_s00262_019_02404_x
crossref_primary_10_1016_j_cell_2012_01_021
crossref_primary_10_3390_ijms20092272
crossref_primary_10_1002_ijc_28889
crossref_primary_10_3390_ijms21249751
crossref_primary_10_18632_oncotarget_25891
crossref_primary_10_1007_s10555_012_9373_9
crossref_primary_10_1007_s12274_022_4473_5
crossref_primary_10_1152_ajpcell_00158_2022
crossref_primary_10_1172_JCI93554
crossref_primary_10_3390_cancers13051005
crossref_primary_10_1038_nrc_2017_6
crossref_primary_10_1631_jzus_B1400221
crossref_primary_10_1021_acsomega_4c06096
crossref_primary_10_1016_j_semcdb_2017_06_027
crossref_primary_10_1038_s41419_020_03308_w
crossref_primary_10_1186_s12935_020_01719_5
crossref_primary_10_3390_ijms232012270
crossref_primary_10_18632_oncotarget_13679
crossref_primary_10_1016_j_freeradbiomed_2014_08_027
crossref_primary_10_1097_MPA_0000000000001504
crossref_primary_10_1038_s41467_021_21993_9
crossref_primary_10_1038_srep19608
Cites_doi 10.1007/s00280-009-1238-8
10.1126/science.1203543
10.1016/j.ccr.2008.11.012
10.1038/nm.2208
10.3892/or_00000502
10.1073/pnas.92.12.5510
10.1074/jbc.271.51.32529
10.1002/cncr.11246
10.1016/S0076-6879(04)81023-1
10.1038/onc.2009.441
10.1038/nature04186
10.1016/j.cell.2009.10.027
10.1002/path.2137
10.1371/journal.pone.0005620
10.1074/jbc.M109.042424
10.1002/jcb.21371
10.1038/nature04695
10.1016/S0079-6603(01)70012-8
ContentType Journal Article
Copyright Copyright National Academy of Sciences Sep 27, 2011
Copyright_xml – notice: Copyright National Academy of Sciences Sep 27, 2011
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7S9
L.6
7X8
5PM
DOI 10.1073/pnas.1113483108
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
Ecology Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Entomology Abstracts
Genetics Abstracts
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList
Virology and AIDS Abstracts

MEDLINE
AGRICOLA

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
EISSN 1091-6490
EndPage 16374
ExternalDocumentID PMC3182724
2471462861
21911388
10_1073_pnas_1113483108
108_39_16369
41352805
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
Feature
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: T32 CA153952
– fundername: NCI NIH HHS
  grantid: U54-CA143868
– fundername: NCI NIH HHS
  grantid: T32 CA130840
– fundername: NCI NIH HHS
  grantid: T32-CA130840
– fundername: NCI NIH HHS
  grantid: U54 CA143868
GroupedDBID ---
-DZ
-~X
.55
0R~
123
29P
2AX
2FS
2WC
4.4
53G
5RE
5VS
85S
AACGO
AAFWJ
AANCE
AAYJJ
ABBHK
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ABZEH
ACGOD
ACHIC
ACIWK
ACNCT
ACPRK
ADQXQ
ADULT
ADXHL
AENEX
AEUPB
AEXZC
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AQVQM
BKOMP
CS3
D0L
DCCCD
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HH5
HQ3
HTVGU
HYE
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
KQ8
L7B
LU7
MVM
N9A
N~3
O9-
OK1
P-O
PNE
PQQKQ
R.V
RHI
RNA
RNS
RPM
RXW
SA0
SJN
TAE
TN5
UKR
W8F
WH7
WOQ
WOW
X7M
XSW
Y6R
YBH
YKV
YSK
ZCA
~02
~KM
-
02
0R
1AW
55
AAPBV
ABFLS
ABPTK
ADACO
ADZLD
AJYGW
ASUFR
DNJUQ
DOOOF
DWIUU
DZ
F20
JSODD
KM
PQEST
RHF
VQA
X
XHC
ZA5
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7S9
L.6
7X8
5PM
ID FETCH-LOGICAL-c565t-ee8c3c2425ff095047a49a33742e80b78db068e41ae7773cfdded03ed96d94a33
ISSN 0027-8424
1091-6490
IngestDate Thu Aug 21 14:12:52 EDT 2025
Sun Aug 24 04:03:07 EDT 2025
Sun Aug 24 04:07:14 EDT 2025
Sat Aug 23 13:26:14 EDT 2025
Thu Apr 03 07:05:56 EDT 2025
Thu Apr 24 22:56:31 EDT 2025
Tue Jul 01 00:47:16 EDT 2025
Wed Nov 11 00:29:40 EST 2020
Thu May 29 08:40:43 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 39
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c565t-ee8c3c2425ff095047a49a33742e80b78db068e41ae7773cfdded03ed96d94a33
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Contributed by Gregg L. Semenza, August 17, 2011 (sent for review July 25, 2011)
Author contributions: C.C.-L.W., D.M.G., and G.L.S. designed research; C.C.-L.W., D.M.G., H.Z., J.C., H.W., P.C., S.I.F., C.-M.W., U.-S.K., and I.O.-L.N. performed research; D.W. contributed new reagents/analytic tools; C.C.-L.W., D.M.G., and G.L.S. analyzed data; and C.C.-L.W. and G.L.S. wrote the paper.
OpenAccessLink https://www.pnas.org/content/pnas/108/39/16369.full.pdf
PMID 21911388
PQID 894733454
PQPubID 42026
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3182724
crossref_citationtrail_10_1073_pnas_1113483108
proquest_miscellaneous_2986466937
proquest_journals_894733454
jstor_primary_41352805
proquest_miscellaneous_894816677
crossref_primary_10_1073_pnas_1113483108
pnas_primary_108_39_16369
pubmed_primary_21911388
ProviderPackageCode RNA
PNE
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-09-27
PublicationDateYYYYMMDD 2011-09-27
PublicationDate_xml – month: 09
  year: 2011
  text: 2011-09-27
  day: 27
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationTitleAlternate Proc Natl Acad Sci U S A
PublicationYear 2011
Publisher National Academy of Sciences
National Acad Sciences
Publisher_xml – name: National Academy of Sciences
– name: National Acad Sciences
References e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_17_2
e_1_3_3_9_2
e_1_3_3_16_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_15_2
e_1_3_3_14_2
e_1_3_3_2_2
e_1_3_3_1_2
e_1_3_3_4_2
e_1_3_3_11_2
e_1_3_3_3_2
e_1_3_3_10_2
References_xml – ident: e_1_3_3_4_2
  doi: 10.1007/s00280-009-1238-8
– ident: e_1_3_3_5_2
  doi: 10.1126/science.1203543
– ident: e_1_3_3_7_2
  doi: 10.1016/j.ccr.2008.11.012
– ident: e_1_3_3_18_2
  doi: 10.1038/nm.2208
– ident: e_1_3_3_17_2
  doi: 10.3892/or_00000502
– ident: e_1_3_3_3_2
  doi: 10.1073/pnas.92.12.5510
– ident: e_1_3_3_12_2
  doi: 10.1074/jbc.271.51.32529
– ident: e_1_3_3_13_2
  doi: 10.1002/cncr.11246
– ident: e_1_3_3_1_2
  doi: 10.1016/S0076-6879(04)81023-1
– ident: e_1_3_3_2_2
  doi: 10.1038/onc.2009.441
– ident: e_1_3_3_6_2
  doi: 10.1038/nature04186
– ident: e_1_3_3_10_2
  doi: 10.1016/j.cell.2009.10.027
– ident: e_1_3_3_16_2
  doi: 10.1002/path.2137
– ident: e_1_3_3_14_2
  doi: 10.1371/journal.pone.0005620
– ident: e_1_3_3_11_2
  doi: 10.1074/jbc.M109.042424
– ident: e_1_3_3_15_2
  doi: 10.1002/jcb.21371
– ident: e_1_3_3_8_2
  doi: 10.1038/nature04695
– ident: e_1_3_3_9_2
  doi: 10.1016/S0079-6603(01)70012-8
SSID ssj0009580
Score 2.5352085
Snippet Primary tumors facilitate metastasis by directing bone marrowderived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we...
Primary tumors facilitate metastasis by directing bone marrow-derived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we...
SourceID pubmedcentral
proquest
pubmed
crossref
pnas
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 16369
SubjectTerms Biological Sciences
Bone marrow
Bone marrow cells
Breast cancer
breast neoplasms
Breast Neoplasms - pathology
Cancer
Cell Line, Tumor
Cell lines
Collagen
Collagen - metabolism
Collagens
crosslinking
Family members
Female
Gene Knockdown Techniques
Humans
Hypoxia
Hypoxia-Inducible Factor 1 - genetics
Hypoxia-Inducible Factor 1 - physiology
Lungs
Metastasis
mice
Neoplasm Metastasis
Rodents
Tumors
Title Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
URI https://www.jstor.org/stable/41352805
http://www.pnas.org/content/108/39/16369.abstract
https://www.ncbi.nlm.nih.gov/pubmed/21911388
https://www.proquest.com/docview/894733454
https://www.proquest.com/docview/2986466937
https://www.proquest.com/docview/894816677
https://pubmed.ncbi.nlm.nih.gov/PMC3182724
Volume 108
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfKuHBBDBhkA2QkDkORS5o4iXOcJlCFWLXDJu2AFDmOI6Kt6dQkEvCX8efxHDtO2q3S4BK1yYvl5P3yPuz3gdCHIgtUtJ9PQLt5hOasIFniecSPpOQs9GXecfpsEc0v6der8Goy-TOKWmqbbCp-35tX8j9chXPAV5Ul-w-ctYPCCfgN_IUjcBiOD-Lx_Nft6mfJCfjVrShVDpRun-POVJ9y7i65KoPgrnW_-VW3IZCpKPRGBXsJuLSUDVc5RaVwKxUUOiQzjq3Wc6vl6j6mYNEvIp4MKSlGTtQucc8XQ4PjPur3lK-XslIb_NfkW1vayJ_y5lrLKpPu7p5N7yxnz1teSKNku2AEk1PCVaHz8cqFWopNiC4EYDMJQENSnUM9lVoAg_1CIqpbiFoJ7bERFHXxIyNwwZzUrV6M9ob_uuvPHdUAskz1M654rdREQFWHNTZowX7nf0s52pDFbrM-DlI1QDoM8Ag99sFB6UJK5-Nyz0wnP5kn7ItKxcGnrRls2EM6JFbV2QWi-3ye7dDdkS108Qw9NU4MPtGI3EcTWT1H-z378bGpZf7xBfp-B6JYQxTPcFljjjVEsYUoXhVYQxRriOIBoriDKLYQfYkuv3y-OJ0T09CDCPAbGiIlE4FQTm5RwCvyaMxpwgPgmC-Zl8Usz7yISTrjMo7jQBSge3MvkHkS5QkFwgO0V60q-RphMNxlIUREOVjQIfV5xMM8o7yYhSILk8xB0_61psJUu1dNV27SHYx00LG94VYXetlNetDxydKBIRj6zAsd5HSkw_0sDZK0w6iDjnpupkaE1ClLaBwEMH8HvbdXQb6rTTteyVVbp77qnxBF4EU4CO-gYarkUhTFQPJKw8NOAQwSmDeDOccbwLEEqrz85pWq_NGVmQdt78c-PXz4izlCT4bv_A3aa9atfAs2e5O96z6Pv8Zc6qs
linkProvider ABC ChemistRy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia-inducible+factor+1+is+a+master+regulator+of+breast+cancer+metastatic+niche+formation&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Wong%2C+Carmen+Chak-Lui&rft.au=Gilkes%2C+Daniele+M.&rft.au=Zhang%2C+Huafeng&rft.au=Chen%2C+Jasper&rft.date=2011-09-27&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=108&rft.issue=39&rft.spage=16369&rft.epage=16374&rft_id=info:doi/10.1073%2Fpnas.1113483108&rft.externalDBID=n%2Fa&rft.externalDocID=10_1073_pnas_1113483108
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F108%2F39.cover.gif
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F108%2F39.cover.gif